The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter phase II trial to assess the efficacy and safety of bevacizumab plus mFOLFOX6 as induction chemotherapy toward R0 surgical resection in advanced colorectal liver metastases with mutant-type KRAS: NEXTO-mt trial.
 
Genki Watanabe
No Relationships to Disclose
 
Yoshihiro Mise
No Relationships to Disclose
 
Masaru Oba
No Relationships to Disclose
 
Akio Saiura
No Relationships to Disclose
 
Yosuke Inoue
No Relationships to Disclose
 
Yu Takahashi
No Relationships to Disclose
 
Yoji Kishi
No Relationships to Disclose
 
Koichi Suyama
No Relationships to Disclose
 
Tadatoshi Takayama
No Relationships to Disclose
 
Tamaki Noie
No Relationships to Disclose
 
Yujiro Nishioka
No Relationships to Disclose
 
Nobuhisa Akamatsu
No Relationships to Disclose
 
Junichi Arita
No Relationships to Disclose
 
Norihiro Kokudo
No Relationships to Disclose
 
Kiyoshi Hasegawa
Honoraria - Chugai Pharma; Eisai; Taiho Pharmaceutical; Takeda
Research Funding - Fujifilm (Inst); Nipro Corporation (Inst); Shimadzu (Inst)